Abstract

Prior studies have demonstrated that the substrate for NO synthesis, l-arginine, can be regenerated from the NOS co-product l-citrulline. This requires the sequential action of two enzymes, argininosuccinate synthetase (AS) and argininosuccinate lyase (AL). AS activity has been shown to be rate-limiting for high output NO synthesis by immunostimulant-activated cells and represents a potential site for metabolic control of NO synthesis. We now demonstrate that NO mediates reversible S-nitrosylation and inactivation of AS in vitro and in lipopolysaccharide-treated cells and mice. Using a novel mass spectrometry-based method, we show that Cys-132 in human AS is the sole target for S-nitrosylation among five Cys residues. Mutagenesis studies confirm that S-nitrosylation of Cys-132 is both necessary and sufficient for the inhibition of AS by NO donors. S-nitroso-AS content is regulated by cellular glutathione levels and selectively influences NO production when citrulline is provided to cells as a protosubstrate of NOS but not when l-arginine is provided. A phylogenetic comparison of AS sequences suggests that Cys-132 evolved as a site for post-translational regulation of activity in the AS in NOS-expressing species, endowing NO with the capacity to limit its own synthesis by restricting arginine availability.

Highlights

  • Nitric oxide (NO)1 is a cell signaling molecule with diverse and important biological functions [1, 2]

  • A phylogenetic comparison of argininosuccinate synthetase (AS) sequences suggests that Cys-132 evolved as a site for post-translational regulation of activity in the AS in NO synthase (NOS)-expressing species, endowing NO with the capacity to limit its own synthesis by restricting arginine availability

  • AS and argininosuccinate lyase (AL) are generally considered in the context of their contribution to the urea cycle of the liver, where AS serves as the rate-limiting enzyme for ammonia detoxification [7], these enzymes endow isoform of nitric-oxide synthase (iNOS)-expressing cells with an Arg/Cit cycle for continuous regeneration of Arg from Cit, providing iNOS with a sustained supply of substrate

Read more

Summary

Introduction

Nitric oxide (NO)1 is a cell signaling molecule with diverse and important biological functions [1, 2]. We previously demonstrated that AS activity is rate-limiting for immunostimulant-induced high output NO production in cultured vascular smooth muscle cells [8], and the Arg/Cit cycle provides the preferred source of Arg to iNOS [13].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call